New prostate cancer treatments extend survival, but result in worse quality of life

A new Australian study has found that men with advanced prostate cancer, who are surviving longer by being treated with a combination of androgen deprivation therapy (ADT) and external beam radiotherapy (EBRT), are reporting poorer health related quality of life than other treatment groups.